Absolute Antibody Revenue and Competitors

Redcar, UK

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Absolute Antibody's estimated annual revenue is currently $5.3M per year.(i)
  • Absolute Antibody's estimated revenue per employee is $155,000

Employee Data

  • Absolute Antibody has 34 Employees.(i)
  • Absolute Antibody grew their employee count by -26% last year.

Absolute Antibody's People

NameTitleEmail/Phone
1
Chief Scientific OfficerReveal Email/Phone
2
NGS and Analytics ManagerReveal Email/Phone
3
Project CoordinatorReveal Email/Phone
4
Scientist I R&DReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$4.5M29-12%N/AN/A
#2
$15.7M1015%N/AN/A
#3
$87.9M40525%$292MN/A
#4
$2.6M47016%$631.7MN/A
#5
$14.9M96-8%$81MN/A
#6
$44.8M2310%$132.9MN/A
#7
$7.6M49-37%N/AN/A
#8
$17.4M11212%N/AN/A
#9
$334.6M134911%£994.6MN/A
#10
$830.2M53568%N/AN/A
Add Company

What Is Absolute Antibody?

Absolute Antibody was founded in 2012 with a vision to make recombinant antibody technology accessible to all. We offer antibody sequencing, engineering and recombinant production as royalty-free custom services, as well as a unique reagents catalog of recombinant antibodies and Fc Fusion proteins, engineered into new and useful formats. Our customers include leading pharmaceutical, biotechnology and diagnostics companies, as well as academic researchers worldwide. Our international customer base is served by our ISO 9001:2015-certified antibody manufacturing facility in Northeast England and additional offices in Boston in the United States and Amsterdam in the Netherlands.

keywords:N/A

N/A

Total Funding

34

Number of Employees

$5.3M

Revenue (est)

-26%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Absolute Antibody News

2021-02-25 - ChromoTek and Absolute Antibody Collaborate on Recombinant Engineered Antibodies

The Nanobody-IgG fusions showcase the power of antibody engineering to open up experimental possibilities and facilitate new avenues of research. MUNICH, Germany and REDCAR, UK (PRWEB) February 25, 2021 ChromoTek GmbH, part of Proteintech specializing in Nanobody-based reagents, and Absolute A ...

2020-12-17 - International Consortium Awarded Eurostars Grant for the Development of First-in-class Treatment of Metastatic Cancer

BARCELONA, Spain (PRWEB) December 17, 2020 ONA Therapeutics, Absolute Antibody and RIC - three leading European companies in the biotech landscape - have been awarded a Eurostars grant for a two-year project that will develop a proprietary biological drug with a unique mode of action for the tr ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$6.7M4048%N/A
#2
$35M3285%N/A
#3
$87.3M38810%N/A
#4
$133.1M48426%N/A
#5
$35M12665%N/A